Vfend and Valacyclovir hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vfend (voriconazole) and Valacyclovir hydrochloride (valacyclovir hydrochloride). Common drug interactions include death among females and photosensitivity reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Vfend and Valacyclovir hydrochloride. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Vfend?

Vfend has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 12,128 Vfend users. Check the latest studies of Vfend.

What is Valacyclovir hydrochloride?

Valacyclovir hydrochloride has active ingredients of valacyclovir hydrochloride. It is often used in herpes zoster. eHealthMe is studying from 12,929 Valacyclovir hydrochloride users. Check the latest studies of Valacyclovir hydrochloride.



On Aug, 12, 2026

68 people who take Vfend and Valacyclovir hydrochloride together, and have interactions are studied.

Vfend and Valacyclovir hydrochloride drug interactions.

What are the common drug interactions of Vfend and Valacyclovir Hydrochloride, by gender? *:

female:

  1. Death
  2. Decreased appetite
  3. Delirium (wild excitement)
  4. Escherichia infection (bacterial infection by escherichia coli)
  5. Fusarium infection (fungal infection)
  6. Gastric disorder (disease of stomach)
  7. Gastrointestinal inflammation (inflammation of stomach and intestine)
  8. Hallucination, visual (seeing things that aren't there)
  9. Hot flush (sudden feelings of heat)
  10. Hypophagia (reduced food intake)

male:

  1. Photosensitivity reaction
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Drug ineffective
  4. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  5. Haemorrhage (bleeding)
  6. Infection
  7. Venoocclusive disease (small veins in the liver are obstructed)
  8. Actinic keratosis (skin disease due to sun exposure)
  9. Anaemia (lack of blood)
  10. Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))

What are the common drug interactions of Vfend and Valacyclovir Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Photosensitivity reaction
  2. Toxic optic neuropathy (optic nerve damage caused by toxic (harmful) substances)
  3. Acute lymphocytic leukaemia (cancer of the white blood cells)
  4. Aplasia (defective development or congenital absence of an organ or tissue)
  5. Drug ineffective
  6. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  7. Haemorrhage (bleeding)
  8. Infection
  9. Venoocclusive disease (small veins in the liver are obstructed)
  10. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)

30-39:

  1. Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Ileus (a painful obstruction of the ileum or other part of the intestine)
  5. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)

40-49:

  1. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  2. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  3. Aggression
  4. Agitation (state of anxiety or nervous excitement)
  5. Altered state of consciousness (altered state of mind)
  6. Anaemia (lack of blood)
  7. Blood lactate dehydrogenase increased
  8. Confusional state
  9. Encephalopathy (functioning of the brain is affected by some agent or condition)
  10. Lung disorder (lung disease)

50-59:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  3. Pruritus (severe itching of the skin)
  4. Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
  5. Richter's syndrome (hairy cell cancer changes in fast growing b cell cancer tumour)
  6. Staphylococcal infection (an infection with staphylococcus bacteria)
  7. Abdominal pain
  8. Anaemia (lack of blood)
  9. Asthenia (weakness)
  10. Death

60+:

  1. Actinic keratosis (skin disease due to sun exposure)
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Blood creatinine increased
  4. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  5. Constipation
  6. Device related infection
  7. Folliculitis (infection of hair root)
  8. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  9. Oral candidiasis (fungal infection of mouth)
  10. Oral herpes (viral infection of mouth)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 17 people, 25.00%
  2. Anaemia (lack of blood): 9 people, 13.24%
  3. Immunodeficiency Disorders: 8 people, 11.76%
  4. Infection: 7 people, 10.29%
  5. Fever: 7 people, 10.29%
  6. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 8.82%
  7. High Blood Pressure: 5 people, 7.35%
  8. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 5 people, 7.35%
  9. Venoocclusive Liver Disease (small veins in the liver are obstructed): 4 people, 5.88%
  10. Stress And Anxiety: 4 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Vfend and Valacyclovir hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vfend and Valacyclovir hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vfend:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vfend and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on voriconazole and valacyclovir hydrochloride (the active ingredients of Vfend and Valacyclovir hydrochloride, respectively), and Vfend and Valacyclovir hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: